MLA
TMDX icon

MB, Levis & Associates’s Transmedics TMDX Stock Holding History

MB, Levis & Associates’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
200
– – ﹤0.01% 159
2026
Q1 		$19.9K Buy
+200
New +$26.1K 0.01% 141

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

MB, Levis & Associates's TMDX Position: Q2 2026 in Review

MB, Levis & Associates held its Transmedics (TMDX) position steady in Q2 2026 at 200 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

MB, Levis & Associates first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $19.9K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • MB, Levis & Associates held 200 shares of Transmedics worth $13.3K as of Q2 2026.
  • MB, Levis & Associates left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #159 holding.
  • MB, Levis & Associates first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • MB, Levis & Associates's Transmedics position peaked at $19.9K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.